These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20616688)

  • 1. Clinical factors related to visual outcome in central serous chorioretinopathy.
    Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
    Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
    Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
    Yalcinbayir O; Gelisken O; Akova-Budak B; Ozkaya G; Gorkem Cevik S; Yucel AA
    Retina; 2014 Apr; 34(4):705-12. PubMed ID: 24100708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foveal thickness can predict visual outcome in patients with persistent central serous chorioretinopathy.
    Furuta M; Iida T; Kishi S
    Ophthalmologica; 2009; 223(1):28-31. PubMed ID: 18849634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early changes in foveal thickness in eyes with central serous chorioretinopathy.
    Hata M; Oishi A; Shimozono M; Mandai M; Nishida A; Kurimoto Y
    Retina; 2013 Feb; 33(2):296-301. PubMed ID: 23023530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations among various functional and morphological tests in resolved central serous chorioretinopathy.
    Kim SW; Oh J; Huh K
    Br J Ophthalmol; 2012 Mar; 96(3):350-5. PubMed ID: 21617156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
    Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
    Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
    Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
    Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy.
    Matsumoto H; Sato T; Kishi S
    Am J Ophthalmol; 2009 Jul; 148(1):105-10.e1. PubMed ID: 19327740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
    Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.
    Suh MH; Seo JM; Park KH; Yu HG
    Am J Ophthalmol; 2009 Mar; 147(3):473-480.e3. PubMed ID: 19054492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central serous chorioretinopathy.
    Marcuson J; Riley T
    Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
    Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.
    Piccolino FC; de la Longrais RR; Ravera G; Eandi CM; Ventre L; Abdollahi A; Manea M
    Am J Ophthalmol; 2005 Jan; 139(1):87-99. PubMed ID: 15652832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
    Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.
    Chen SN; Hwang JF; Tseng LF; Lin CJ
    Ophthalmology; 2008 Dec; 115(12):2229-34. PubMed ID: 19041477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of fundus autofluorescence gray values with vision and microperimetry in resolved central serous chorioretinopathy.
    Oh J; Kim SW; Kwon SS; Oh IK; Huh K
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):179-84. PubMed ID: 22159007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography].
    Yu H; Xia GY; Gao MH; Yu J; Zhang YY
    Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):508-15. PubMed ID: 21914265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.